Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.

Transplantation proceedings - 1 Dec 2009

Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Fukuhara T, Kotoh K, Shimoda S, Kato M, Maehara Y

Abstract excerpt

UNLABELLED: Although it has been recognized that interferon (IFN) treatment is crucial for recurrent hepatitis C after liver transplantation, its benefits have not been determined among patients without a sustained viral response (SVR). METHODS: Eighty patients who received IFN plus ribavirin treatment after living donor liver transplantation were grouped as follows: group I (n = 18) SVR; group II (n = 25) no-SVR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Aspartate Aminotransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Survival

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Transplantation

Share to Living Donors

Share to Ribavirin

Source

Identifiers

PMID: 20005378
DOI: 10.1016/j.transproceed.2009.08.070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.PMID 20005378Read ↗

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.Semantic proximity Read ↗

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.Semantic proximity Read ↗

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Semantic proximity Read ↗

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.Semantic proximity Read ↗

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.Semantic proximity Read ↗

Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.Semantic proximity Read ↗

Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review.Semantic proximity Read ↗

Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.Semantic proximity Read ↗

Long-term outcome of hepatitis C infection after liver transplantation.Semantic proximity Read ↗

Long-term outcome of hepatitis C virus infection after liver transplantation.Semantic proximity Read ↗

Living donor liver transplantation for patients with hepatitis C virus cirrhosis: Tokyo experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.